MEK/ERK addiction in CNL/aCML
Oncotarget
.
2017 Nov 3;8(59):99215-99216.
doi: 10.18632/oncotarget.22283.
eCollection 2017 Nov 21.
Authors
Meenu Kesarwani
1
,
Zachary Kincaid
1
,
Mohammad Azam
1
Affiliation
1
Mohammad Azam: Division of Experimental Hematology and Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
PMID:
29245892
PMCID:
PMC5725083
DOI:
10.18632/oncotarget.22283
No abstract available
Keywords:
CNL; ERK1/2; KSR1; Trametinib; aCML.
Publication types
Editorial
Grants and funding
R01 CA155091/CA/NCI NIH HHS/United States